SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001437749-24-013721
Filing Date
2024-04-29
Accepted
2024-04-29 16:34:50
Documents
3

Document Format Files

Seq Description Document Type Size
1 FORM DEFA14A tgtx20240426_defa14a.htm DEFA14A 9100
2 rnotice01.jpg GRAPHIC 309503
3 rnotice02.jpg GRAPHIC 231516
  Complete submission text file 0001437749-24-013721.txt   755742
Mailing Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014 (212) 554-4484
TG THERAPEUTICS, INC. (Filer) CIK: 0001001316 (see all company filings)

IRS No.: 363898269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-32639 | Film No.: 24891669
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)